Strata Critical Medical Inc Warrants
SRTAW
SRTAW was delisted on the 6th of May, 2026.
11 hedge funds and large institutions have $2.64M invested in Strata Critical Medical Inc Warrants in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 1 closing their positions.
63% more capital invested
Capital invested by funds: $1.62M → $2.64M (+$1.02M)
0.53% more ownership
Funds ownership: 9.62% → 10.15% (+0.53%)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
8% less funds holding
Funds holding: 12 → 11 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$200K |
| 2 |
Two Sigma Investments
New York
|
+$2.85K |
| 3 |
LP
LMR Partners
London,
United Kingdom
|
+$57 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
Ionic Capital Management
New York
|
-$34.1K |
| 2 |
Walleye Capital
New York
|
-$26.3K |
| 3 |
HF
HRT Financial
New York
|
-$1.19K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$16 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Walleye Capital
New York
| $806K | -$26.3K | -92,137 | -4% |
|
2
Goldman Sachs
New York
| $805K | – | – | – |
|
|
3
Morgan Stanley
New York
| $490K | +$200K | +700,000 | +100% |
|
|
LP
4
LMR Partners
London,
United Kingdom
| $361K | +$57 | +200 | +0% |
|
|
ICM
5
Ionic Capital Management
New York
| $130K | -$34.1K | -119,434 | -24% |
|
|
CAC
6
Cowen and Company
New York
| $16.6K | – | – | – |
|
|
7
Two Sigma Investments
New York
| $13.1K | +$2.85K | +10,000 | +37% |
|
|
SCM
8
Saba Capital Management
New York
| $11.2K | – | – | – |
|
|
HF
9
HRT Financial
New York
| $3K | -$1.19K | -4,164 | -28% |
|
|
TPCW
10
TD Private Client Wealth
New York
| $210 | – | – | – |
|
|
TRCT
11
Tower Research Capital (TRC)
New York
| $8 | – | – | – |
|
|
12
UBS Group
Zurich,
Switzerland
| – | -$16 | -69 | Closed |
|
SRTAW Hedge Fund Activity: Q4 2023 in Review
11 of the 6,863 institutional investors tracked by Wall St. Rank reported a position in Strata Critical Medical Inc Warrants (SRTAW) for Q4 2023, worth a combined $2.64M — up 63% from $1.62M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of SRTAW and 0 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 3 added.
The largest buyer was Morgan Stanley, adding an estimated $200K. The largest seller was Ionic Capital Management, cutting an estimated $34.1K.
- 11 institutional investors held Strata Critical Medical Inc Warrants (SRTAW) as of Q4 2023, down from 12 in Q3 2023.
- Funds reported $2.64M of Strata Critical Medical Inc Warrants stock for Q4 2023, up 63% quarter-over-quarter.
- 0 funds opened new Strata Critical Medical Inc Warrants positions in Q4 2023 and 1 closed out, a net change of -1 holder.
- The largest Strata Critical Medical Inc Warrants buyer in Q4 2023 was Morgan Stanley, an estimated $200K added.
- The largest Strata Critical Medical Inc Warrants seller in Q4 2023 was Ionic Capital Management, an estimated $34.1K sold.
Based on aggregated 13F filings for Q4 2023.